マラリア診断の市場規模、シェア、成長分析：製品別、技術別、最終用途別、地域別 - 産業予測（2025年～2032年）

マラリア診断の世界市場規模は、2023年に8億4,451万米ドルと評価され、2024年の8億8,420万米ドルから2032年には12億7,681万米ドルに成長し、予測期間（2025年～2032年）のCAGRは4.7%で成長する見通しです。

世界のマラリア診断市場は、分子診断や迅速診断検査（RDT）などの診断技術の進歩に後押しされ、大きな成長を遂げています。これらの技術革新は感度、特異性、使いやすさを向上させ、特に資源が限られた地域で迅速な診断を可能にしています。マラリアの早期発見に対する意識の高まりは、政府のイニシアティブや世界基金のような組織からの支援と相まって、市場の拡大をさらに促しています。しかし、僻地における不十分な医療インフラや、低所得国における検査の価格や利用しやすさに関する懸念など、課題も残っています。さらに、一部の検査の精度に関する問題や規制上の障害も、成長を制限する可能性があります。マラリアと効果的に闘うためには、手頃な価格で信頼性が高く、文化的に適切な診断ソリューションを開発するために、官民の協力が不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 主要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

マラリア診断の市場規模：製品別 & CAGR（2025年～2032年）

• 市場概要
• 機器
• キットと試薬

マラリア診断の市場規模：技術別 & CAGR（2025年～2032年）

• 市場概要
• 顕微鏡検査
• 迅速診断検査
• 分子診断検査
  • 従来のPCR
  • リアルタイムPCR
• その他の技術

マラリア診断の市場規模：最終用途別 & CAGR（2025年～2032年）

• 市場概要
• クリニック
• 病院
• 診断センター
• その他

マラリア診断の市場規模 & CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022年～2024年）

主要企業プロファイル

• Abbott Laboratories（米国）
• Bio-Rad Laboratories, Inc.（米国）
• Siemens Healthineers AG（ドイツ）
• Thermo Fisher Scientific Inc.（米国）
• F. Hoffmann-La Roche Ltd（スイス）
• bioMerieux SA（フランス）
• Beckman Coulter, Inc.（米国）
• Cepheid Inc.（米国）
• Danaher Corporation（米国）
• Hologic, Inc.（米国）
• Illumina, Inc.（米国）
• Qiagen NV（オランダ）
• Sysmex Corporation（日本）
• Nikon Corporation（日本）
• Olympus Corporation（日本）
• DiaSorin S.p.A.（イタリア）
• Trinity Biotech plc（アイルランド）
• FujiFilm Corporation（日本）

結論と推奨事項

Global Malaria Diagnostics Market size was valued at USD 844.51 million in 2023 and is poised to grow from USD 884.2 million in 2024 to USD 1276.81 million by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global malaria diagnostics market has experienced significant growth, propelled by advancements in diagnostic technologies like molecular diagnostics and rapid diagnostic tests (RDTs). These innovations have enhanced sensitivity, specificity, and user-friendliness, enabling quicker diagnoses, particularly in resource-limited areas. Increasing awareness of early malaria detection, coupled with government initiatives and support from organizations like the Global Fund, has further stimulated market expansion. However, challenges persist, including inadequate healthcare infrastructure in remote regions, as well as concerns about the affordability and accessibility of tests in low-income countries. Additionally, issues regarding the accuracy of some tests and regulatory obstacles may limit growth. Collaborative efforts from public and private sectors are essential to develop affordable, reliable, and culturally appropriate diagnostic solutions to combat malaria effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Malaria Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Malaria Diagnostics Market Segments Analysis

Global Malaria Diagnostics Market is segmented by Product, Technology, End-use and Region. Based on Product, the market is segmented into Instruments and Kits & reagents. Based on Technology, the market is segmented into Microscopy, Rapid diagnostic tests, Molecular diagnostic tests and Other technologies. Based on End-use, the market is segmented into Clinics, Hospitals, Diagnostic centers and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is significantly influenced by regions heavily impacted by malaria, especially in sub-Saharan Africa and certain areas of Asia. In these regions, there is a strong demand for effective malaria diagnostics driven by the critical need for accurate and prompt diagnosis. Timely identification of malaria cases is essential for the effective management and control of the disease, making malaria diagnostics an indispensable part of public health efforts. As the burden of malaria remains high, the focus on developing and implementing reliable diagnostic tools will continue to be a major driver for the market's growth and evolution.

Restraints in the Global Malaria Diagnostics Market

The global malaria diagnostics market faces significant restraints due to inadequate investment in research and development. This shortfall restricts the emergence of innovative and advanced diagnostic technologies, as there is insufficient funding for research initiatives aimed at creating tests that are more sensitive, specific, and cost-effective. Consequently, the lack of financial support hampers progress in developing better diagnostic solutions, potentially stalling efforts to enhance malaria detection and management. Without increased investment in R&D, the market may struggle to keep pace with the evolving needs for effective malaria diagnostics, ultimately impacting control and prevention strategies globally.

Market Trends of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is witnessing significant growth, particularly driven by expansion into emerging markets across Asia, Latin America, and Africa. As healthcare expenditures rise alongside heightened awareness of infectious diseases, these regions are becoming hotspots for diagnostic innovation. Government initiatives aimed at combating malaria further bolster this trend, creating a favorable environment for diagnostic companies. To effectively tap into these burgeoning markets, businesses are focusing on developing cost-effective and culturally sensitive diagnostic solutions that cater to local needs, ultimately enhancing accessibility and improving health outcomes in malaria-endemic regions. This strategic focus is poised to accelerate market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Malaria Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & reagents

Global Malaria Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Microscopy
• Rapid diagnostic tests
• Molecular diagnostic tests
  • Conventional PCR
  • Real-time PCR
• Other technologies

Global Malaria Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Clinics
• Hospitals
• Diagnostic centers
• Other end-users

Global Malaria Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-use)
  • US
  • Canada
• Europe (Product, Technology, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FujiFilm Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations